DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development. This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII… Read More
o2h co-discovery has announced that the Cambridge and London Life Sciences Showcase will return for its second edition during JP Morgan Healthcare Week 2027 in San Francisco. The event provides emerging companies with an international platform to present their science, innovation and growth opportunities directly to investors,… Read More
The full scientific programme for the 2026 ‘From Insight to Decision’ e-symposium, which is taking place on 2 and 8 December, has been announced by CN Bio. The event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip (OOC) use within existing R&D strategies. Launched in… Read More
The Drug Discovery Innovators & Investors (DDII) UK Conference has announced a new panel, From Rules to Runway: How UK Regulation Can Accelerate or Obstruct Drug Development, examining how organisations can navigate the UK regulatory environment while supporting innovation and accelerating the development of new therapies. The conference takes place… Read More
Early bird rates for the Drug Discovery Innovators & Investors (DDII) UK Conference close on 30 September 2026. Taking place on 4 November 2026 at etc.venues Monument in London, UK, the conference brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors for a focused day of… Read More
Experts from across the drug discovery ecosystem will explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery at the Drug Discovery Innovators & Investors (DDII) Digital Forum on 30 September. The Forum is free to attend. Register for the full event, or simply join one of the… Read More
Chris Molloy, Chief Executive Officer of the UK BioIndustry Association (BIA), will explore the UK’s role in the changing global drug R&D landscape in his keynote address at the Drug Discovery Innovators & Investors (DDII) UK Conference on 4 November 2026 at etc.venues Monument, London, UK. Read More
Join us on 30 September for the Drug Discovery Innovators & Investors (DDII) Digital Forum, where experts from across the drug discovery ecosystem explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery. The Forum is free to attend. Register for the full event, or simply join one… Read More
The Drug Discovery Innovators & Investors (DDII) London, UK Conference brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors for a focused day of discussion, collaboration and networking. Taking place at etc.venues in Monument, London, UK on Wednesday 4 November 2026, the conference will examine the… Read More
The Drug Discovery Innovators & Investors UK Conference will take place on 4 November 2026 at etc.venues Monument, London. Here’s a look at what attendees can expect from the day. Practical, hands-on content with a focus on technology As previously announced, the day includes panels on… Read More
The Drug Discovery Innovators & Investors (DDII) UK Conference will take place at etc.venues Monument, London, on Wednesday 4 November. The conference brings together R&D leaders, lab managers, decision-makers from pharma and biotech companies, industry suppliers, researchers, start-ups, and investors to discuss key challenges in UK drug development. Read More
We’re excited to announce the launch of Drug Discovery Innovators & Investors (DDII) – a new event series from Drug Discovery World. The three-part global event series focuses on technology, innovation, and investment in early-stage drug discovery. Bringing together senior executives, R&D leaders, lab managers, and decision-makers from pharma and… Read More
Drug Discovery World (DDW) is launching new series of events aimed at connecting innovation with investment in early-stage drug discovery. The Drug Discovery Innovators and Investors three-part series will comprise a digital forum (30 September 2026), and two in-person events (London, UK, 4 November 2026,… Read More
The American Association for Cancer Research (AACR) Annual Meeting 2026 took place 17-22 April 2026. Here we share some of the themes discussed and key data presented at the event. Dominant themes Allan Jordan, Vice President, Oncology Drug Discovery, Sygnature Discovery, shared his key take-homes messages… Read More
Swiss Biotech Day, first launched in 2021, will be held this year at Congress Center Basel on 4-5 May. The day provides a chance to explore advances in R&D, manufacturing, data management, AI and innovative financing. The 2026 Plenary Sessions will include a fireside session… Read More
Advanced Therapies 2026 took place 17 -18 March 2026 in London, UK. DDW asked industry experts for their key takeaways from the event. Michael Baker, Director, Advanced Therapies, FUJIFILM Biotechnologies Walking away from Advanced Therapies Week UK 2026, the focus is no longer just on… Read More
